Inventor
CHEDID LOUIS
FR31 patents
⚠️ This page may combine multiple inventors who share the name “CHEDID LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANVAR
23 patentsUS4235771ANov 25, 1980
Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
ANVAR52 citations94
US4186194AJan 29, 1980
Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
ANVAR36 citations94
US4153684AMay 8, 1979
Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
ANVAR35 citations92
US4036953AJul 19, 1977
Process for preparing vaccine adjuvant
ANVAR39 citations92
US4185089AJan 22, 1980
Immunological adjuvant constituted by the p-amino-phenyl derivative of N-acetyl-muramyl-L-alanyl-D-isoglutamine
ANVAR46 citations89
US4152423AMay 1, 1979
Immunological agents
ANVAR23 citations81
US3976544AAug 24, 1976
Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
ANVAR19 citations81
US4220637ASep 2, 1980
Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
ANVAR9 citations74
US4158052AJun 12, 1979
Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-isoglutamine
ANVAR15 citations74
US4125603ANov 14, 1978
Stabilized water-in-oil emulsions and compositions
ANVAR11 citations74
US4693998ASep 15, 1987
Novel compounds of the muramyl peptide
ANVAR9 citations73
US4461761AJul 24, 1984
Oligomers of compounds of the muramyl-peptide type and medicaments containing them
ANVAR10 citations73
US4401659AAug 30, 1983
Muramyl-peptides fixed to peptide-polymers and pharmaceutical compositions containing them
ANVAR8 citations73
US4396607AAug 2, 1983
Muramyl peptide derivatives and pharmaceutical compositions
ANVAR16 citations73
US4370265AJan 25, 1983
Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
ANVAR13 citations72
US4939122AJul 3, 1990
Lipophile derivatives of muramylpeptides having properties of activating macrophages and compositions containing them
ANVAR9 citations71
US4639512AJan 27, 1987
Conjugates of haptenes and muramyl-peptides, endowed with immunogenic activity and compositions containing them
ANVAR19 citations71
US4427659AJan 24, 1984
Muramyl peptide substituted on a peptide nitrogen and medicaments containing the same
ANVAR14 citations71
US4272524AJun 9, 1981
N-Acyl-muramyl peptide derivatives having anti-infectious infections properties
ANVAR7 citations71
US4042678AAug 16, 1977
Water-soluble agents having mitogenic properties obtained from nocardia cells, and processes for the preparation thereof
ANVAR9 citations66
US4335111AJun 15, 1982
Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
ANVAR6 citations63
US4172125AOct 23, 1979
Oil-free adjuvant compositions containing N-acetyl-muramyl-L-alanyl-D-glutamic acid and method of use
ANVAR5 citations63
US4201768AMay 6, 1980
Process for obtaining agents having mitogenic and/or adjuvant properties from Nocardia cells and compositions containing such agents
ANVAR3 citations58
VACSYN SA
3 patentsUS6063380AMay 16, 2000
Enhanced immunogenic vaccine
VACSYN SA44 citations91
US5932208AAug 3, 1999
Compositions and methods for the use of such compositions in human therapeutics, characterized by the association of a muramyl peptide with a cytokine
VACSYN SA20 citations89
US6267968B1Jul 31, 2001
MDP derivatives and conjugates having haematipoietic function stimulating activity, and compositions containing same
VACSYN SA10 citations70